These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32021165)

  • 21. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
    Cherukula K; Uthaman S; Park IK
    Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual Receptor-Targeted and Redox-Sensitive Polymeric Micelles Self-Assembled from a Folic Acid-Hyaluronic Acid-SS-Vitamin E Succinate Polymer for Precise Cancer Therapy.
    Yang Y; Li Y; Chen K; Zhang L; Qiao S; Tan G; Chen F; Pan W
    Int J Nanomedicine; 2020; 15():2885-2902. PubMed ID: 32425522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.
    Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y
    Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
    Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
    Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymatic multifunctional biodegradable polymers for pH- and ROS-responsive anticancer drug delivery.
    Su M; Xiao S; Shu M; Lu Y; Zeng Q; Xie J; Jiang Z; Liu J
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111067. PubMed ID: 32388121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pH/ROS Cascade-Responsive Charge-Reversal Nanosystem with Self-Amplified Drug Release for Synergistic Oxidation-Chemotherapy.
    Dai L; Li X; Duan X; Li M; Niu P; Xu H; Cai K; Yang H
    Adv Sci (Weinh); 2019 Feb; 6(4):1801807. PubMed ID: 30828537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery.
    Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z
    Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
    Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
    Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitosan derivatives functionalized dual ROS-responsive nanocarriers to enhance synergistic oxidation-chemotherapy.
    Liao JX; Huang QF; Li YH; Zhang DW; Wang GH
    Carbohydr Polym; 2022 Apr; 282():119087. PubMed ID: 35123755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced Cellular Internalization and On-Demand Intracellular Release of Doxorubicin by Stepwise pH-/Reduction-Responsive Nanoparticles.
    Li F; Chen WL; You BG; Liu Y; Yang SD; Yuan ZQ; Zhu WJ; Li JZ; Qu CX; Zhou YJ; Zhou XF; Liu C; Zhang XN
    ACS Appl Mater Interfaces; 2016 Nov; 8(47):32146-32158. PubMed ID: 27933846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem.
    Hu JJ; Lei Q; Peng MY; Zheng DW; Chen YX; Zhang XZ
    Biomaterials; 2017 Jun; 128():136-146. PubMed ID: 28325685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.
    Yang J; Lv Q; Wei W; Yang Z; Dong J; Zhang R; Kan Q; He Z; Xu Y
    Drug Deliv; 2018 Nov; 25(1):807-814. PubMed ID: 29553858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-Activating Therapeutic Nanoparticle: A Targeted Tumor Therapy Using Reactive Oxygen Species Self-Generation and Switch-on Drug Release.
    Kang RH; Kim Y; Kim JH; Kim NH; Ko HM; Lee SH; Shim I; Kim JS; Jang HJ; Kim D
    ACS Appl Mater Interfaces; 2021 Jul; 13(26):30359-30372. PubMed ID: 34142813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A robust strategy for preparation of sequential stimuli-responsive block copolymer prodrugs via thiolactone chemistry to overcome multiple anticancer drug delivery barriers.
    Ke W; Yin W; Zha Z; Mukerabigwi JF; Chen W; Wang Y; He C; Ge Z
    Biomaterials; 2018 Feb; 154():261-274. PubMed ID: 29149720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutathione and Reactive Oxygen Species Dual-Responsive Block Copolymer Prodrugs for Boosting Tumor Site-Specific Drug Release and Enhanced Antitumor Efficacy.
    Yin W; Ke W; Lu N; Wang Y; Japir AAMM; Mohammed F; Wang Y; Pan Y; Ge Z
    Biomacromolecules; 2020 Feb; 21(2):921-929. PubMed ID: 31961134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. l-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells.
    Niu S; Bremner DH; Wu J; Wu J; Wang H; Li H; Qian Q; Zheng H; Zhu L
    Drug Deliv; 2018 Nov; 25(1):1275-1288. PubMed ID: 29847177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.